Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Medisan ; 21(7)jul. 2017.
Article in Spanish | LILACS | ID: biblio-894635

ABSTRACT

Mediante una extensa revisión bibliográfica fue posible profundizar en el tema de las ictericias obstructivas o las colestasis, sobre todo en los aspectos más importantes de su definición, semiogénesis, clasificación, etiopatogenia, manifestaciones clínicas, estudios de laboratorio e imagenológicos, además del diagnóstico, la evolución, el pronóstico y tratamiento, con el objetivo de proporcionar los elementos más novedosos de cada uno de ellos, a través de un enfoque didáctico y una base científica, desde la óptica del internista, para así facilitar conocimientos prácticos acerca del síndrome


It was possible to deepen in the topic of the obstructive icterus or cholestasis by means of an extensive literature review, mainly in the most important aspects of its definition, semiogenesis, classification, etiopathogenesis, clinical manifestations, laboratory and imagenological studies, besides diagnosis, clinical course, prognosis and treatment in this respect, with the objective of providing the most original elements of each of them, through a didactic approach and a scientific base, from the internist's optics, and in this way, to facilitate practical knowledge about the syndrome


Subject(s)
Humans , Male , Female , Cholestasis, Extrahepatic , Cholestasis/classification , Cholestasis/diagnosis , Cholestasis/therapy , Cholestasis, Intrahepatic , Jaundice, Obstructive , Hyperbilirubinemia
2.
Rev. GASTROHNUP ; 14(2): 49-54, ene.15, 2012. ilus
Article in Spanish | LILACS | ID: lil-648027

ABSTRACT

Introducción: El Síndrome de Alagille corresponde a una alteración autosómica dominante con expresión variable. Se caracteriza por colestasis crónica con escasez de los conductos biliares interlobulares asociada a alteraciones cardiovasculares, oftálmicas, sistema esquelético, riñones y facies característica. Su distribución es mundial con frecuencia de 1 por cada 100000 nacidos vivos. Objetivo: Describir las características clínicas, la evolución y la sobrevida de catorce pacientes, con diagnóstico de Síndrome de Alagille atendidos en un período de 16 años en Medellín, Colombia. Materiales y métodos: Es un trabajo observacional descriptivo de reporte de casos de los hallazgos morfológicos y la evolución de los pacientes con diagnóstico de Síndrome de Alagille. Resultados: Grupo compuesto por ocho niños y seis niñas, con edades entre los dos meses y los diez años al momento de diagnóstico. El síndrome completo se presentó en 28%. Los hallazgos más frecuentes, estenosis valvular de la arteria pulmonar y la alteración vertebral se presentaron en el 79%. Tres pacientes 21%, fallecieron, uno de ellos después de recibir trasplante hepático. De los once sobrevivientes dos niñas fueron sometidas a trasplante y se encuentran en buenas condiciones. Los nueve restantes padecen hepatopatía colestásica crónica y reciben tratamiento médico. Conclusión: El Síndrome de Alagille se debe tener en cuenta en el diagnóstico de colestasis crónica infantil. Para establecer la distribución y frecuencia de esta enfermedad en nuestro país es necesario desarrollar investigaciones que idealmente incluyan el estudio de la mutación genética en los pacientes y su familia cercana.


Introduction: The Alagille Syndrome is an autosomic dominant disorder with variable expression. Chronic cholestasis, characteristic facial appearance and abnormalities heart, skeleton, eye, kydnes with hypoplasia of the biliary ducts. Initial description in France, with mundial distribution her frecuence is 1/100000. Objective: To describe the clinical characteristic and evolutions of fourteen patients with diagnosis Alagille Syndrome in Medellín Colombia. Materials and methods: Descriptive retrospective study with variables obtained from clinical records of patients with diagnosis Alagille Syndrome. Results: Eight boys and six girls. The age at diagnosis varied two months at nine years. Complete syndrome was present in 28%. The most frecuent alterations were valvular stenosis pulmonary artery and failure of anterior vertebral arch fusion (butterfly vertebrae) 79%. The clinical evolution was variable, death occurred in three patients 21%, one girl post liver transplantation. Nine children had chronic hepatopathy controlled with medical treatment and two girls had liver transplantation with satisfactory evolution. Conclusions: In Colombia, the poblational incidence is not defined it is necessary to know the distribution of syndrome at future study.


Subject(s)
Humans , Male , Female , Child , Cholestasis/classification , Cholestasis/complications , Cholestasis/diagnosis , Cholestasis/epidemiology , Cholestasis/physiopathology , Cholestasis/genetics , Cholestasis/metabolism , Cholestasis/prevention & control , Cholestasis/psychology , Cholestasis/rehabilitation , Alagille Syndrome/classification , Alagille Syndrome/complications , Alagille Syndrome/diagnosis , Alagille Syndrome/epidemiology , Alagille Syndrome/genetics , Alagille Syndrome/history , Alagille Syndrome/pathology , Alagille Syndrome/prevention & control
3.
J. pediatr. (Rio J.) ; 86(1): 40-44, jan.-fev. 2010. graf, tab
Article in English, Portuguese | LILACS | ID: lil-542901

ABSTRACT

Objetivo: Avaliar se os parâmetros clínicos e laboratoriais poderiam auxiliar no diagnóstico diferencial da colestase neonatal (CN) intra- e extra-hepática. Métodos: Estudo retrospectivo de pacientes com CN hospitalizados na Clínica de Hepatologia Pediátrica do Hospital de Clínicas da Universidade Estadual de Campinas (UNICAMP), Campinas (SP), entre dezembro de 1980 e março de 2005. A abordagem para o diagnóstico da CN foi padronizada. De acordo com o diagnóstico, os pacientes foram classificados em dois grupos: I (colestase neo natal intra-hepática) e II (colestase neonatal extrahepática). Para verificar se havia associação com a variável categórica, os testes de qui-quadrado e Mann-Whitney foram utilizados com correções para idade para a análise de covariância (ANCOVA). A determinação da precisão das variáveis clínicas e laboratoriais para a diferenciação dos grupos foi realizada através da análise da curva ROC. Resultados: Cento e sessenta e oito pacientes foram avaliados (grupo I = 54,8 por cento e grupo II = 45,2 por cento). Nos pacientes com menos de 60 dias de vida, houve predominância de causas intra-hepáticas, enquanto que naqueles com mais de 60 dias, houve predominância de etiologia extrahepática (p < 0,001). A mediana de peso ao nascer foi mais baixa no grupo I (p = 0,003), assim como o comprimento ao nascer (p = 0,007). Os valores da mediana de bilirrubina direta foram mais altos no grupo II (p = 0,006). Os valores de gama glutamil transferase (GGT) (10 vezes mais altos do que o limite de normalidade) apresentaram sensibilidade de 56,3 por cento, especificidade de 91,5 por cento e acurácia de 75,7 por cento para o diagnóstico de colestase extra-hepática. Conclusão: No presente estudo, a CN extra-hepática apresentou maior peso e comprimento ao nascer, hipocolia/acolia fecal, colúria, hepatomegalia, aumento de GGT (10,8 vezes mais alto do que o limite de normalidade) e um atraso no encaminhamento para a investigação no hospital terciário.


Objective: To evaluate if clinical and laboratory parameters could assist in the differential diagnosis of intra and extra-hepatic neonatal cholestasis (NC). Methods: Retrospective study of NC patients admitted at the Pediatric Hepatology Outpatient Clinic of the teaching hospital of Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil, between December 1980 and March 2005. The approach to the diagnosis of NC was standardized. According to diagnosis, patients were classified into two groups: I (intra-hepatic neonatal cholestasis) and II (extra-hepatic neonatal cholestasis). In order to verify if there was association with the categorical variable, the chi-square and Mann-Whitney tests were used, with corrections for age for the covariance analysis (ANCOVA). The determination of accuracy of the clinical and laboratory variables for differentiation of the groups was made using the analysis of the ROC curve. Results: One hundred and sixty-eight patients were evaluated (group I = 54.8 percent and group II = 45.2 percent). In the patients with less than 60 days of life there was predominance of intra-hepatic causes, whereas, in those older than 60 days, there was predominance of extra-hepatic etiology (p < 0.001). Median birth weight was lower in group I (p = 0.003), as well as length at birth (p = 0.007). Median values of direct bilirubin were higher in group II (p = 0.006). Values of gamma-glutamyltransferase (GGT) (10 times higher than the limit of normality) presented sensitivity of 56.3 percent, specificity of 91.5 percent, and accuracy of 75.7 percent for the diagnosis of extra-hepatic cholestasis. Conclusion: In the present study, extra-hepatic NC presented greater weight and length at birth, fecal hypocholia/acholia, choluria, hepatomegaly, increase in GGT (10.8 times higher than the limit of normality), and a delay for investigation in the tertiary center.


Subject(s)
Female , Humans , Infant , Male , Cholestasis/diagnosis , Biomarkers/blood , Brazil/epidemiology , Cholestasis/classification , Cholestasis/enzymology , Cholestasis/epidemiology , Diagnosis, Differential , Epidemiologic Methods , gamma-Glutamyltransferase/blood
4.
Rev. GASTROHNUP ; 12(1): S27-S30, ene.15 2010.
Article in Spanish | LILACS | ID: lil-645079

ABSTRACT

La colestasis, tiene incidencia de 1:60-375 ictéricos a las 2 semanas de edad, es potencialmente grave, presentan riesgos inmediatos como coagulopatías por hemorragia severa ante el déficit de la absorción de la vitamina K, y con su diagnóstico precoz, se identifican patologías que tienen tratamiento, incluso, trasplante hepático. Como consecuencia de la colestasis, hay retención de sales biliares, daño celular hepático, y descenso de la bilis a nivel intestinal, que ocasionan mala digestión de grasas y proteínas, con defectos en las vitaminas liposolubles. Existen hepatopatías primariassecundarias a una serie de entidades genéticas y metabólicas, y colestasis secundarias a otros problemas, que en el adulto generan enfermedad hepática. Es necesario establecer protocolos deidentificación del niño con ictericia.


Cholestasis has 1:60-375 incidence of jaundice at 2 weeks of age, are potentially serious, immediateand present risk of severe bleeding coagulopathy to the shortfall in the absorption of vitamin K, andearly diagnosis, identify diseases that are treatable, even liver transplantation.As a result of cholestasis, there is retention of bile salts, liver cell damage and decrease of bile in the intestine, causing poor digestion of fats and protein, with defects in soluble vitamins. There are primaryliver disease secondary to a variety of metabolic and genetic entities, and cholestasis secondary toother problems, generated in the adult liver disease. It is necessary to establish protocols for the identification of children with jaundice.


Subject(s)
Child , Cholestasis/classification , Cholestasis/complications , Cholestasis/diagnosis , Cholestasis/epidemiology , Cholestasis/physiopathology , Cholestasis/pathology , Cholestasis/blood , Bile Ducts/injuries , Bile Ducts/metabolism , Bile Ducts/pathology , Bile , Alagille Syndrome/classification , Alagille Syndrome/genetics , Alagille Syndrome/pathology , Vitamin K
5.
Yonsei Medical Journal ; : 939-942, 2003.
Article in English | WPRIM | ID: wpr-205349

ABSTRACT

Clinical variants of hepatitis A include the prolonged, relapsing and cholestatic forms. Here, the first childhood case of hepatitis A, with a combination of the relapsing and cholestatic forms is presented, a 14-year old boy. In the first phase of the illness, while the AST and ALT levels were declined, th total and direct bilirubin and GGT were increased. The patient was thought to have the cholestatic form of hepatitis A. Du to intense pruritus and high bilirunbin levels, ursodeoxycholic acid (UDCA) therapy was started. On the 17th day, the decreased AST and ALT levels began to increase, reaching levels as high as 484 U/L and 862 U/L, respectively. The UDCA treatment was stopped on the 64th day. On the 164th day, all his laboratory parameters were within normal limits, but the anti-HAV IgM was still positive.


Subject(s)
Adolescent , Humans , Male , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Cholestasis/classification , Hepatitis A/complications , Ursodeoxycholic Acid/therapeutic use
6.
Article in English | IMSEAR | ID: sea-64945
7.
Medicina (Ribeiräo Preto) ; 30(2): 159-63, abr.-jun. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-211591

ABSTRACT

A icterícia é um sinal clínico comum a várias condiçöes patológicas. As icterícias obstrutivas ocorrem quando há algum obstáculo ao livre fluxo de bile entre o sítio produtor (hepatócito) e o duodeno e säo causadas por drogas, doenças imunológicas, afecçöes congênitas, parasitas, cálculos ou tumores. Para o cirurgiäo, as icterícias obstrutivas extra-hepáticas säo as mais importantes e podem näo cursar com as clássicas elevaçöes enzimáticas. O aumento da pressäo ductal e a contaminaçäo da bile têm efeitos deletérios näo só para a célula hepática como para todo o sistema imunológico. O benefício da descompressäo pré-operatória ainda é objeto de discussäo e a completa avaliaçäo pré-operatória pode diminuir as taxas de morbidade cirúrgica.


Subject(s)
Humans , Cholestasis, Extrahepatic , Cholestasis/etiology , Cholestasis/classification , Cholestasis/physiopathology
8.
Bol. Hosp. San Juan de Dios ; 44(3): 185-6, mayo-jun. 1997. tab
Article in Spanish | LILACS | ID: lil-202618

ABSTRACT

La colestasia es un síndrome caracterizado clínicamente por ictericia y prurito y que desde el punto de vista fisiopatológico es provocado por cualquier interferencia a la secreción bibliar desde el hepatocito mismo hasta la papila de Vater y el esfínter de Oddi


Subject(s)
Humans , Cholestasis/diagnosis , Clinical Diagnosis , Ursodeoxycholic Acid/therapeutic use , Cholestasis/classification , Cholestasis/drug therapy , Cholestyramine Resin/therapeutic use , Pruritus/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL